Literature DB >> 9233736

BLEED: a classification tool to predict outcomes in patients with acute upper and lower gastrointestinal hemorrhage.

M H Kollef1, J D O'Brien, G R Zuckerman, W Shannon.   

Abstract

OBJECTIVE: To develop an outcome prediction tool (BLEED: ongoing bleeding, low systolic blood pressure, elevated prothrombin time, erratic mental status, unstable comorbid disease) for clinical use in patients with either acute upper or acute lower gastrointestinal (GI) hemorrhage.
DESIGN: A cohort study.
SETTING: Barnes Hospital and Jewish Hospital, two private university-affiliated teaching hospitals in St. Louis, MO. PATIENTS: Four hundred sixty-five patients with either acute upper or acute lower GI hemorrhage admitted from the emergency department.
INTERVENTIONS: Admission of patients to the intensive care unit or hospital ward was determined by emergency department physicians, without use or knowledge of BLEED criteria. Patients meeting any BLEED criteria at their initial assessment in the emergency department were classified as "high-risk." All other patients were classified as "low-risk."
MEASUREMENTS AND MAIN RESULTS: The main outcome measure was the occurrence of an inhospital complication, defined as recurrent GI hemorrhage, surgery to control the source of hemorrhage, and hospital mortality. Patients classified as high-risk had significantly greater rates of inhospital complications at both Barnes Hospital (relative risk, 2.47; 95% confidence interval, 1.38 to 4.44; p < .001) and Jewish Hospital (relative risk, 8.94; 95% confidence interval, 3.92 to 20.41; p < .001) compared with patients classified as low-risk. Patients classified as high-risk at either hospital were significantly more likely to develop additional organ system derangements, require a greater number of transfused units of packed red blood cells, and have longer hospital stays compared with patients classified as low-risk (p < .006). The BLEED classification also identified a greater frequency of intensive care admission for both low-risk (RR, 4.21; 95% Cl, 2.24 to 7.89) and high-risk (relative risk, 1.58; 95% confidence interval, 1.23 to 2.02) patients at Barnes Hospital compared with those patients at Jewish Hospital, although no beneficial effects on patient outcome were reported.
CONCLUSIONS: The BLEED classification, applied at initial emergency department evaluation and before admission, predicts hospital outcomes for patients with acute upper or lower GI hemorrhage. This outcome prediction tool also identified variations in intensive care utilization between two hospitals.

Entities:  

Mesh:

Year:  1997        PMID: 9233736     DOI: 10.1097/00003246-199707000-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  31 in total

Review 1.  Trends on gastrointestinal bleeding and mortality: where are we standing?

Authors:  Ahmed Mahmoud El-Tawil
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

2.  Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Peter W Angus; Sanjay Saran Baijal; Soon Koo Baik; Yusuf Bayraktar; Yogesh Kumar Chawla; Gourdas Choudhuri; Jin Wook Chung; Roberto de Franchis; H Janaka de Silva; Hitendra Garg; Pramod Kumar Garg; Ahmed Helmy; Ming-Chih Hou; Wasim Jafri; Ji-Dong Jia; George K Lau; Chang-Zheng Li; Hock Foong Lui; Hitoshi Maruyama; Chandra Mohan Pandey; Amrender S Puri; Rungsun Rerknimitr; Peush Sahni; Anoop Saraya; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose D Sollano; Justin Wu; Rui Yun Xu; Surender Kumar Yachha; Chunqing Zhang
Journal:  Hepatol Int       Date:  2011-02-19       Impact factor: 6.047

Review 3.  Diagnosis and management of lower gastrointestinal bleeding.

Authors:  Jürgen Barnert; Helmut Messmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

4.  ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding.

Authors:  Lisa L Strate; Ian M Gralnek
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

Review 5.  Management of Diverticular Bleeding: Evaluation, Stabilization, Intervention, and Recurrence of Bleeding and Indications for Resection after Control of Bleeding.

Authors:  Mohammed Iyoob Mohammed Ilyas; Eric J Szilagy
Journal:  Clin Colon Rectal Surg       Date:  2018-06-22

6.  A multicentre development and validation study of a novel lower gastrointestinal bleeding score-The Birmingham Score.

Authors:  Samuel C L Smith; Alina Bazarova; Efe Ejenavi; Maria Qurashi; Uday N Shivaji; Phil R Harvey; Emma Slaney; Michael McFarlane; Graham Baker; Mohamed Elnagar; Sarah Yuzari; Georgios Gkoutos; Subrata Ghosh; Marietta Iacucci
Journal:  Int J Colorectal Dis       Date:  2019-12-16       Impact factor: 2.571

7.  Acute lower gastrointestinal hemorrhages in geriatric patients.

Authors:  Antonio Ríos; Mariano J Montoya; José Manuel Rodríguez; Andrés Serrano; Joaquín Molina; Pascual Parrilla
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

8.  Characteristics of Short-stay Critical Care Admissions From Emergency Departments in Maryland.

Authors:  Obiora O Chidi; Sarah M Perman; Adit A Ginde
Journal:  Acad Emerg Med       Date:  2017-05-08       Impact factor: 3.451

9.  Neural network prediction of severe lower intestinal bleeding and the need for surgical intervention.

Authors:  Tyler J Loftus; Scott C Brakenridge; Chasen A Croft; Robert Stephen Smith; Philip A Efron; Frederick A Moore; Alicia M Mohr; Janeen R Jordan
Journal:  J Surg Res       Date:  2016-12-30       Impact factor: 2.192

10.  Comparison of Three Risk Scores to Predict Outcomes of Severe Lower Gastrointestinal Bleeding.

Authors:  Marine Camus; Dennis M Jensen; Gordon V Ohning; Thomas O Kovacs; Rome Jutabha; Kevin A Ghassemi; Gustavo A Machicado; Gareth S Dulai; Mary E Jensen; Jeffrey A Gornbein
Journal:  J Clin Gastroenterol       Date:  2016-01       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.